Table 2.
Clinicopathological parameters | Number | Survival status | P valuea | |
---|---|---|---|---|
Alive | Dead | |||
Sex | 0.179 | |||
Male | 79 | 32 | 47 | |
Female | 42 | 23 | 19 | |
Age (years) | 0.365 | |||
≤50 | 58 | 29 | 29 | |
>50 | 63 | 26 | 37 | |
WHO glioma grade | 0.00017 | |||
I | 7 | 7 | 0 | |
II | 31 | 20 | 11 | |
III | 38 | 13 | 25 | |
IV | 45 | 15 | 30 | |
SASH1 expression | <0.0001 | |||
Low | 81 | 25 | 56 | |
High | 40 | 30 | 10 | |
WHO classification | ||||
Choroid plexus papilloma | 2 | |||
Pilocytic astrocytoma | 4 | |||
Subependymoma | 1 | |||
Fibrillary astrocytoma | 9 | |||
Protoplasmic astrocytoma | 6 | |||
Gemistocytic astrocytoma | 5 | |||
Oligodendroglioma | 4 | |||
Ependymoma | 3 | |||
Oligoastrocytoma | 4 | |||
Anaplastic astrocytoma | 29 | |||
Anaplastic oligoastrocytoma | 4 | |||
Anaplastic oligodendroglioma | 5 | |||
Glioblastoma | 43 | |||
Gliosarcoma | 2 |
aStatistical analyses were performed using Fisher's exact probability. P < 0.05 was considered as statistically significant.